Evidence map›Paper›PMID 40619487›Full record

ArticleAnnals of surgical oncology2025

A CT-Based Deep Learning Radiomics Nomogram for Early Recurrence Prediction in Pancreatic Cancer: A Multicenter Study.

Xiao Guan, Jinsong Liu, Lei Xu, Wenwen Jiang, Chengfeng Wang

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiao Guan *State Key Lab of Molecular Oncology and Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jinsong Liu *Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lei Xu *Department of General Surgery, Lu'an Hospital of Anhui Medical University, Anhui, China.
Wenwen Jiang *State Key Lab of Molecular Oncology and Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chengfeng WangState Key Lab of Molecular Oncology and Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. drwangcf1962@163.com.

Funding

Chinese Academy of Medical Sciences Initiative for Innovative Medicine 2022-I2M-1- 010National Natural Science Foundation of China 81802463National Natural Science Foundation of China 81972314
6 · The paper itself

Abstract

backgroundEarly recurrence (ER) following curative-intent surgery remains a major obstacle to improving long-term outcomes in patients with pancreatic cancer (PC). The accurate preoperative prediction of ER could significantly aid clinical decision-making and guide postoperative management. PATIENTS AND

methodsA retrospective cohort of 493 patients with histologically confirmed PC who underwent resection was analyzed. Contrast-enhanced computed tomography (CT) images were used for tumor segmentation, followed by radiomics and deep learning feature extraction. In total, four distinct feature selection algorithms were employed. Predictive models were constructed using random forest (RF) and support vector machine (SVM) classifiers. The model performance was evaluated by the area under the receiver operating characteristic curve (AUC). A comprehensive nomogram integrating feature scores and clinical factors was developed and validated.

resultsAmong all of the constructed models, the Inte-SVM demonstrated superior classification performance. The nomogram, incorporating the Inte-feature score, CT-assessed lymph node status, and carbohydrate antigen 19-9 (CA19-9), yielded excellent predictive accuracy in the validation cohort (AUC = 0.920). Calibration curves showed strong agreement between predicted and observed outcomes, and decision curve analysis confirmed the clinical utility of the nomogram.

conclusionsA CT-based deep learning radiomics nomogram enabled the accurate preoperative prediction of early recurrence in patients with pancreatic cancer. This model may serve as a valuable tool to assist clinicians in tailoring postoperative strategies and promoting personalized therapeutic approaches.

Indexed as

Deep LearningNeoplasm Recurrence, LocalNomogramsPancreatic NeoplasmsTomography, X-Ray ComputedAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRadiomicsRetrospective StudiesROC CurveDeep learningEarly recurrencePancreatic cancerRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.